|
Reference #:
2005-315
Inventors/Contributors
Michael R. Charlton, M.D.
Description
The severity of non-alcoholic fatty liver disease (NAFLD) can be determined with a high degree of accuracy using a simple model, incorporating measurement of circulating levels of the hormone dehydroepiandrosterone (DHEA). This model provides novel evidence for relative DHEA deficiency in patients with more severe NAFLD.
Patent Status
Pending |
|
Contact
Nathan L. Stacy, Licensing Manager
stacy.nathan@mayo.edu
|
|
Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905
|
Phone: (507) 538-1652
Fax: (507) 284-5410
|
|
|
